The convergence of AI-driven engineering biology and emerging technologies advancing globally networked autonomous biofoundries

Read full text
Authors: Ryan R. Cochrane, Leandro Vieira dos Santos, Yizhi Cai
Cited by: 3
References: 54

Abstract

Since the emergence of synthetic biology, biofoundries have developed as enabling infrastructures that scale engineering biology globally. Landmark initiatives, such as Genome Project-Write, JCVI-syn3.0, Sc2.0, SynMoss and the Synthetic Human Genome Project, have significantly advanced the feasibility of constructing chromosome-sized DNA and revealed key principles of genome function and design. Nevertheless, the intrinsic complexity of cellular systems and the resource-intensive nature of experimental design-build-test-learn cycles continue to constrain innovation. Recent advances in artificial intelligence (AI), whole-cell modelling and digital twinning are now creating opportunities for self-improving, AI-driven biofoundries that seamlessly integrate in silico design and validation with miniaturised and automated in vitro testing. This review surveys the technologies shaping AI-driven synthetic biology, highlighting their convergence with automation, digitisation and miniaturisation to enable fully autonomous biofoundries that unify computational design, automated fabrication and data-driven learning within a single adaptive framework.

Fields of Study & Subjects

Gene Regulatory Network Analysis Pluripotent Stem Cells Research 3D Printing in Biomedical Research

Publication details

Journal / source
Current Opinion in Biotechnology
Publisher
Elsevier BV
Volume
99
Pages
103503–103503
Publication date
1 May 2026
Language
EN